Drug Database
Back to search

Netherlands· NL-9b32bbb2bdda

Bleomycine Accord 15000 IE Poeder voor oplossing voor injectie/infusie

A bleomycin product containing bleomycinesulfaat, registered in Netherlands by Accord Healthcare B.V.. The same ATC class is registered in 15 of our 19 countries.

ATC L01DC01

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedBleomycine Accord 15000 IE Poeder voo…ATCL01DC01REGISTER NO.NL-9b32bbb2bddaPACKS LISTED1CHECKEDSeptember 29, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about bleomycinesulfaatAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Bleomycin is registered in 15 of 19 countries.

Countries holding a registration under ATC L01DC01 (bleomycin), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 9 of them publish a price we can compare per daily dose
Search bleomycin products by name

Bleomycin · ATC L01DC01

15 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)
Active substance
BLEOMYCINESULFAAT
Manufacturer
Accord Healthcare B.V.
Country
Netherlands (NL)
ATC code
L01DC01
ATC class
Bleomycin
Defined daily dose
3 mg, P
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    117383

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

212 interactions on record for bleomycin.

Graded by severity as the source publishes them — 33 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check bleomycin against other medicinesHow interaction checks work

Bleomycin · interactions on record

212 records

  • 33 severe
  • 105 moderate
  • 15 minor
  • 59 info

Most severe, free to view

  • CladribineL01BB04severe
  • Brentuximab vedotinL01FX05severe
  • Brentuximab vedotinL01XC12severe
  • Talimogene laherparepvecL01XL02severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Bleomycin in 9 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All bleomycin products

Authorised across Europe · EMA

The same active substance is authorised in 15 EEA countries. Names it is sold under:

  • Austria · Bleomycin Accord, Bleomycin Baxter
  • Belgium · Bleomycine Accord
  • Czechia · Bleomycin Accord
  • Germany · Bleo-Cell, Bleomycin Accord
  • Denmark · Bleomycin Accord, Bleomycin Baxter
  • Spain · Bleomicina Accord, Bleomicina Viatris
  • Finland · Bleomycin Accord
  • France · Bleomycine Accord
  • United Kingdom (Northern Ireland) · Bleomycin, Bleomycin Accord Healthcare
  • Iceland · Bleomycin Baxter
  • Norway · Bleomycin Accord, Bleomycin Baxter
  • Poland · Bleomedac, Bleomycyna
  • Portugal · Bleomicina Accord
  • Romania · Bleomicină Accord
  • Sweden · Bleomycin Accord, Bleomycin Baxter

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/30048dda-aa57-48c3-a31b-4b392c6dd2b4
GET /v1/drugs/30048dda-aa57-48c3-a31b-4b392c6dd2b4?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Poeder voor oplossing voor injectie of infusie",
  "route": "Intramusculair gebruik, Intraveneus gebruik, Intra-arterieel gebruik, Subcutaan gebruik, Intratumoraal gebruik, Intrapleuraal gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h117383_smpc.pdf",
  "strength": null,
  "atc_label": "Bleomycin",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg117383",
  "excipients": [
    "NATRIUMHYDROXIDE (E 524)",
    "STIKSTOF (E 941)",
    "ZOUTZUUR (E 507)"
  ],
  "substances": [
    "BLEOMYCINESULFAAT"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h117383.pdf",
  "authorised_at": "2018/06/11",
  "procedure_number": "NL/H/4560/001",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "117383",
  "additional_monitoring": "N"
}
API referenceMCP serverPlans

See everything about bleomycin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console